Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Therapeutic Effect of Y-27632 on Tumorigenesis and Cisplatin-Induced Peripheral Sensory Loss through RhoA-NF-κB.

Zhu Y, Howard GA, Pittman K, Boykin C, Herring LE, Wilkerson EM, Verbanac K, Lu Q.

Mol Cancer Res. 2019 Sep;17(9):1910-1919. doi: 10.1158/1541-7786.MCR-19-0024. Epub 2019 Jun 12.

PMID:
31189689
2.

On the prevalence of racial discrimination in the United States.

Lee RT, Perez AD, Boykin CM, Mendoza-Denton R.

PLoS One. 2019 Jan 10;14(1):e0210698. doi: 10.1371/journal.pone.0210698. eCollection 2019.

3.

Reducing negative affect and increasing rapport improve interracial mentorship outcomes.

Leitner JB, Ayduk Ö, Boykin CM, Mendoza-Denton R.

PLoS One. 2018 Apr 4;13(4):e0194123. doi: 10.1371/journal.pone.0194123. eCollection 2018.

4.

National Beef Quality Audit-2016: In-plant survey of carcass characteristics related to quality, quantity, and value of fed steers and heifers.

Boykin CA, Eastwood LC, Harris MK, Hale DS, Kerth CR, Griffin DB, Arnold AN, Hasty JD, Belk KE, Woerner DR, Delmore RJ, Martin JN, VanOverbeke DL, Mafi GG, Pfeiffer MM, Lawrence TE, McEvers TJ, Schmidt TB, Maddock RJ, Johnson DD, Carr CC, Scheffler JM, Pringle TD, Stelzleni AM, Gottlieb J, Savell JW.

J Anim Sci. 2017 Jul;95(7):2993-3002. doi: 10.2527/jas.2017.1543.

PMID:
28727109
5.

National Beef Quality Audit - 2016: Survey of carcass characteristics through instrument grading assessments.

Boykin CA, Eastwood LC, Harris MK, Hale DS, Kerth CR, Griffin DB, Arnold AN, Hasty JD, Belk KE, Woerner DR, Delmore RJ, Martin JN, VanOverbeke DL, Mafi GG, Pfeiffer MM, Lawrence TE, McEvers TJ, Schmidt TB, Maddock RJ, Johnson DD, Carr CC, Scheffler JM, Pringle TD, Stelzleni AM, Gottlieb J, Savell JW.

J Anim Sci. 2017 Jul;95(7):3003-3011. doi: 10.2527/jas.2017.1544.

PMID:
28727107
6.

Comparison between active (pumped) and passive (diffusive) sampling methods for formaldehyde in pathology and histology laboratories.

Lee EG, Magrm R, Kusti M, Kashon ML, Guffey S, Costas MM, Boykin CJ, Harper M.

J Occup Environ Hyg. 2017 Jan;14(1):31-39.

7.

δ-Catenin, a Wnt/β-catenin modulator, reveals inducible mutagenesis promoting cancer cell survival adaptation and metabolic reprogramming.

Nopparat J, Zhang J, Lu JP, Chen YH, Zheng D, Neufer PD, Fan JM, Hong H, Boykin C, Lu Q.

Oncogene. 2015 Mar 19;34(12):1542-52. doi: 10.1038/onc.2014.89. Epub 2014 Apr 14.

8.

EC144 is a potent inhibitor of the heat shock protein 90.

Shi J, Van de Water R, Hong K, Lamer RB, Weichert KW, Sandoval CM, Kasibhatla SR, Boehm MF, Chao J, Lundgren K, Timple N, Lough R, Ibanez G, Boykin C, Burrows FJ, Kehry MR, Yun TJ, Harning EK, Ambrose C, Thompson J, Bixler SA, Dunah A, Snodgrass-Belt P, Arndt J, Enyedy IJ, Li P, Hong VS, McKenzie A, Biamonte MA.

J Med Chem. 2012 Sep 13;55(17):7786-95. doi: 10.1021/jm300810x. Epub 2012 Aug 31.

PMID:
22938030
9.

Structure-based design of 2,6,7-trisubstituted-7H-pyrrolo[2,3-d]pyrimidines as Aurora kinases inhibitors.

Le Brazidec JY, Pasis A, Tam B, Boykin C, Wang D, Marcotte DJ, Claassen G, Chong JH, Chao J, Fan J, Nguyen K, Silvian L, Ling L, Zhang L, Choi M, Teng M, Pathan N, Zhao S, Li T, Taveras A.

Bioorg Med Chem Lett. 2012 Jun 15;22(12):4033-7. doi: 10.1016/j.bmcl.2012.04.085. Epub 2012 Apr 25.

PMID:
22607669
10.

Synthesis, SAR and biological evaluation of 1,6-disubstituted-1H-pyrazolo[3,4-d]pyrimidines as dual inhibitors of Aurora kinases and CDK1.

Le Brazidec JY, Pasis A, Tam B, Boykin C, Black C, Wang D, Claassen G, Chong JH, Chao J, Fan J, Nguyen K, Silvian L, Ling L, Zhang L, Choi M, Teng M, Pathan N, Zhao S, Li T, Taveras A.

Bioorg Med Chem Lett. 2012 Mar 1;22(5):2070-4. doi: 10.1016/j.bmcl.2012.01.019. Epub 2012 Jan 18.

PMID:
22326168
11.

Design, synthesis, and biological evaluation of pyrazolopyrimidine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (part I).

Zhang L, Fan J, Chong JH, Cesena A, Tam BY, Gilson C, Boykin C, Wang D, Aivazian D, Marcotte D, Xiao G, Le Brazidec JY, Piao J, Lundgren K, Hong K, Vu K, Nguyen K, Gan LS, Silvian L, Ling L, Teng M, Reff M, Takeda N, Timple N, Wang Q, Morena R, Khan S, Zhao S, Li T, Lee WC, Taveras AG, Chao J.

Bioorg Med Chem Lett. 2011 Sep 15;21(18):5633-7. doi: 10.1016/j.bmcl.2011.06.129. Epub 2011 Jul 13.

PMID:
21798738
12.

Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation.

Boykin C, Zhang G, Chen YH, Zhang RW, Fan XE, Yang WM, Lu Q.

Br J Cancer. 2011 Mar 1;104(5):781-9. doi: 10.1038/bjc.2011.10. Epub 2011 Feb 8. Erratum in: Br J Cancer. 2012 Mar 13;106(6):1248.

13.

ADAM8 enhances osteoclast precursor fusion and osteoclast formation in vitro and in vivo.

Ishizuka H, García-Palacios V, Lu G, Subler MA, Zhang H, Boykin CS, Choi SJ, Zhao L, Patrene K, Galson DL, Blair HC, Hadi TM, Windle JJ, Kurihara N, Roodman GD.

J Bone Miner Res. 2011 Jan;26(1):169-81. doi: 10.1002/jbmr.199.

14.

A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment.

Hiruma Y, Kurihara N, Subler MA, Zhou H, Boykin CS, Zhang H, Ishizuka S, Dempster DW, Roodman GD, Windle JJ.

Hum Mol Genet. 2008 Dec 1;17(23):3708-19. doi: 10.1093/hmg/ddn266. Epub 2008 Sep 2.

15.

Exercise and the heart. Good, benign, or evil?

Lavie CJ, Milani RV, Squires RW, Boykin C.

Postgrad Med. 1992 Feb 1;91(2):130-4, 143-50. Review.

PMID:
1738734
16.

Reflections on being in nursing for twenty years.

Boykin C.

Vt Regist Nurse. 1979 Jul:2-5. No abstract available.

PMID:
261499

Supplemental Content

Loading ...
Support Center